DnB Asset Management’s Bio-Techne TECH Stock Holding History

DnB Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$732K	Hold	10,367	–	–	﹤0.01%	685
2026 Q1	$542K	Buy	+10,367	New	+$622K	﹤0.01%	744
2025 Q2	–	Sell	-25,752	Closed	-$1.51M	–	773
2025 Q1	$1.51M	Sell	25,752 -1,692	-6%	-$115K	0.01%	603
2024 Q4	$1.98M	Buy	27,444 +1,366	+5%	+$100K	0.01%	586
2024 Q3	$2.08M	Hold	26,078	–	–	0.01%	559
2024 Q2	$1.87M	Buy	26,078 +2,815	+12%	+$207K	0.01%	567
2024 Q1	$1.64M	Sell	23,263 -4,374	-16%	-$313K	0.01%	574
2023 Q4	$2.13M	Sell	27,637 -31,239	-53%	-$2.06M	0.01%	532
2023 Q3	$4.01M	Buy	58,876 +2,368	+4%	+$187K	0.02%	395
2023 Q2	$4.61M	Sell	56,508 -11,081	-16%	-$891K	0.03%	369
2023 Q1	$5.01M	Buy	67,589 +43,064	+176%	+$3.32M	0.03%	362
2022 Q4	$2.03M	Buy	+24,525	New	+$1.95M	0.01%	505

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DnB Asset Management's TECH Position: Q2 2026 in Review

DnB Asset Management held its Bio-Techne (TECH) position steady in Q2 2026 at 10,367 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

DnB Asset Management first reported a position in TECH in Q4 2022 and has held it in 12 quarters since. The position peaked at $5.01M in Q1 2023. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

DnB Asset Management held 10,367 shares of Bio-Techne worth $732K as of Q2 2026.
DnB Asset Management left its Bio-Techne share count unchanged in Q2 2026.
Bio-Techne made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #685 holding.
DnB Asset Management first reported a position in Bio-Techne in Q4 2022 and has held it in 12 quarters since.
DnB Asset Management's Bio-Techne position peaked at $5.01M in Q1 2023.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.